The global pediatric oncology market size was USD 37.22 Billion in 2021 and is expected to register a revenue CAGR of 9.5% during the forecast period. Pediatric oncology market revenue growth is primarily driven by factors such as increasing occurrence of cancer among children, rising prevalence of childhood obesity across the globe, surge in awareness of available treatment for cancer, and rising investments in R&D by pharma companies. Cancer diagnosed in children and young adults (those under the age of 15) is referred to as childhood cancer. There are now several viable options for treating cancer, which vary depending on type and stage of the disease.
The report sheds light on details about every market player in the global Pediatric Oncology Market along with its global status, product portfolio financial standing, and business expansion plan and license agreement. The key players in the market are adopting various key strategies such as mergers and acquisitions, partnerships, joint ventures, collaborations and product launches to strengthen their market position and enhance their product base.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Pediatric Oncology market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
United Therapeutics Corporation, APEIRON Biologics AG, Baxter, CELLECTAR BIOSCIENCES, INC, Pfizer, Inc., Bayer AG, MacroGenics, Inc., Sartorius AG, Merck & Co., Inc., BioNTech SE, and Dr. Reddy’s Laboratories Ltd
Emergen Research has segmented the global Pediatric Oncology market on the basis of type, application, end-use, and region:
Indication Outlook (Revenue, USD Billion; 2019-2030)
Leukemia
Neuroblastoma
Brain Cancers
Retinoblastoma
Lymphoma
Others
Treatment Outlook (Revenue, USD Billion; 2019-2030)
Chemotherapy
Radiotherapy
Tumor Surgery
Blood & Marrow Transplantation
End-Use Outlook (Revenue, USD Billion; 2019-2030)
Hospitals
Specialty Clinics
Cancer & Radiation Therapy Centers
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Pediatric Oncology Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Pediatric Oncology Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.